Evelo Biosciences, Inc. - stock earnings
EVLO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -12.4 million USD | ? USD |
| 2023Q2 | -21.1 million USD | ? USD |
| 2023Q1 | -25.3 million USD | ? USD |
| 2022Q4 | -23.5 million USD | ? USD |
| 2022Q3 | -30.6 million USD | ? USD |
| 2022Q2 | -30.6 million USD | ? USD |
| 2022Q1 | -29.9 million USD | ? USD |
| 2021Q4 | -28.7 million USD | ? USD |
| 2021Q3 | -33.7 million USD | ? USD |
| 2021Q2 | -31.6 million USD | ? USD |
| 2021Q1 | -28.2 million USD | ? USD |
| 2020Q4 | -29.1 million USD | ? USD |
| 2020Q3 | -20.9 million USD | ? USD |
| 2020Q2 | -20.7 million USD | ? USD |
| 2020Q1 | -23.0 million USD | ? USD |
| 2019Q4 | -22.6 million USD | ? USD |
| 2019Q3 | -21.6 million USD | ? USD |
| 2019Q2 | -20.9 million USD | ? USD |
| 2019Q1 | -20.3 million USD | ? USD |
| 2018Q4 | -15.4 million USD | ? USD |
| 2018Q3 | -15.9 million USD | ? USD |
| 2018Q2 | -15.1 million USD | ? USD |
| 2018Q1 | -10.5 million USD | ? USD |
| 2017Q4 | -8.1 million USD | ? USD |
| 2017Q3 | -8.2 million USD | ? USD |
| 2017Q2 | -6.4 million USD | ? USD |
| 2017Q1 | -5.4 million USD | ? USD |
| 2016Q4 | -13.3 million USD | ? USD |
EVLO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.3 million USD | ? USD |
| 2022 | -114.5 million USD | ? USD |
| 2021 | -122.2 million USD | ? USD |
| 2020 | -93.7 million USD | ? USD |
| 2019 | -85.7 million USD | ? USD |
| 2018 | -53.9 million USD | ? USD |
| 2017 | -28.0 million USD | ? USD |
| 2016 | -13.3 million USD | ? USD |
EVLO
Price: $0.05
52 week price:
Earnings Per Share: -15.64 USD
P/E Ratio: -1.81
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 71715
Market Capitalization: 778294